IP Library › Assignment 019825/0880

Patent Assignment

Reel/Frame 019825/0880

Change of Name

Recorded: 2007-09-10 Pages: 27

View PDF Order Certified Copy

Assignor

ZLB BEHRING GMBH

Executed: 2006-12-01

Assignee

CSL BEHRING GMBH

EMIL VON BEHRING STRASSE 76, MARBURG, D-35041, GERMANY

Covered Properties (50)

Inactivation of Human Immunodeficiency Virus (Hiv) in Protein-Containing Solutions by Phenols

Patent: 4,886,779 →

Application: 07/166,421 →

Spray Head for the Administration of a Multi-Component Material by Means of Gas

Patent: 4,925,108 →

Application: 07/226,327 →

Pasteurized, Isoagglutinin-Free Factor Viii Preparation and a Process for Its Production

Patent: 5,043,428 →

Application: 07/538,695 →

A Material for Affinity Chromatography Which Is a Sulfated Polysaccharide Bonded to an Insoluable Polymer

Patent: 5,116,962 →

Application: 07/554,075 →

Process for the Preparation of a Pasteurized and Iron-Free Human Transferrin and the Use Thereof

Patent: 5,252,715 →

Application: 07/804,927 →

One-Component Tissue Adhesive and a Process for the Production Thereof

Patent: 5,407,671 →

Application: 07/983,613 →

Process for the Preparation of a Pasteurized Immunoglobulin Preparation Using Ethanol

Patent: 5,248,767 →

Application: 07/989,953 →

Use of Complement Inhibitors for the Preparation of a Pharmaceutical for the Prophylaxis and Therapy of Inflammatory Intestinal and Skin Disorders as Well as Purpura

Patent: 6,248,365 →

Application: 08/087,058 →

Process for the Preparation of a Stable Factor Viii

Patent: 5,424,401 →

Application: 08/166,156 →

Bovine Ovary Cell Line (Frov) for Virus Replication

Patent: 5,804,430 →

Application: 08/208,272 →

Pasteurized, Purified Von Willebrand Factor Concentrate and a Process for the Preparation Thereof

Patent: 6,239,261 →

Application: 08/253,232 →

Stable Fibrinogen Solution

Patent: 6,277,961 →

Application: 08/272,281 →

Process for the Purification of Factor Xiii, Monoclonal Antibodies Against Factor Xiiia, the Preparation and Use Thereof

Patent: 5,688,919 →

Application: 08/275,656 →

Use of Transglutaminases as Immunosuppressants

Patent: 5,464,615 →

Application: 08/310,038 →

One-Component Tissue Adhesive and a Process for the Production Thereof

Patent: 6,500,427 →

Application: 08/326,254 →

Process for the Pasteurization of Plasma or Concentrates of Blood Coagulation Factors Ii, Vii, Ix and X

Patent: 6,346,277 →

Application: 08/415,166 →

Process for the Production of a Virus-Free Concentrate of Thrombin

Patent: 5,723,123 →

Application: 08/465,191 →

Transglutaminases as Immunosuppressants

Patent: 5,695,753 →

Application: 08/468,058 →

Apparatus for Spraying a Mixture of Two Components

Patent: 5,605,255 →

Application: 08/494,524 →

Process for the Inactivation of Viruses with the Aid of Acridine Derivatives

Patent: 6,831,086 →

Application: 08/568,820 →

Component Mixing Apparatus and System Including a Movable Cannula

Patent: 5,743,312 →

Application: 08/629,630 →

Process for Removing Aromatic Heterocyclic Compounds Product- Containing Solutions

Patent: 5,883,256 →

Application: 08/757,089 →

Use of C1-Inactivation for Therapy of Certain Diseases

Patent: 5,939,389 →

Application: 08/854,365 →

Cell Line and Processes for the Replicating Rabies Viruses and Detecting Them Quantitatively

Patent: 5,830,638 →

Application: 08/913,317 →

Procedure for the Detection of High Virus Concentrations in Blood Plasma and/or Blood Serum by Means of the Polymerase Chain Reaction

Patent: 6,183,999 →

Application: 09/198,243 →

Labeled Primer for Use in and Detection of Target Nucleic Acids

Patent: 6,248,526 →

Application: 09/210,657 →

Monoclonal Antibody Which Is Specific for Activated Coagulation Factor Vii, and Its Use

Patent: 6,479,245 →

Application: 09/234,504 →

Multi-Pass Heat Exchanger

Patent: 6,334,484 →

Application: 09/294,896 →

Protease for Activating Clotting Factor Vii

Patent: 6,528,299 →

Application: 09/295,316 →

Process and Agent for Sanitation of Contaminations Caused by Viruses

Patent: 6,399,356 →

Application: 09/364,050 →

Transgenic Coagulation Factor Xiii Defective Animal and Its Use for Testing Wound Healing and Bleeding

Patent: 6,207,877 →

Application: 09/404,208 →

Flexible Wound Covering Based on Fibrin and Process for Its Production

Patent: 6,310,267 →

Application: 09/434,104 →

Stabilized Antithrombin Iii Preparation

Patent: 6,514,940 →

Application: 09/456,991 →

Publication: US 2002/0172933

Pharmaceutical Preparation for the Treatment of Inflammatory Processes

Patent: 6,399,572 →

Application: 09/492,790 →

Process for the Inactivation of Viruses

Patent: 6,468,778 →

Application: 09/572,471 →

Process for the Preparation in Pure Form of the Protease Activating Blood Clotting Factor Vii, Its Proenzyme or a Mixture of Both Proteins by Means of Ion-Exchange Chromatography

Patent: 6,677,440 →

Application: 09/632,627 →

Process for the Preparation in Pure Form of the Protease Activating Blood Clotting Vii, Its Proenzyme or a Mixture of Both Proteins by Means of Affinity Chromatography

Patent: 6,670,455 →

Application: 09/632,974 →

Process for Purifying Factor Vii and Activated Factor Vii

Patent: 6,573,056 →

Application: 09/768,294 →

Publication: US 2001/0007901

Flexible Wound Covering Based on Fibrin and Process for Its Production

Patent: 6,486,377 →

Application: 09/846,320 →

Publication: US 2001/0025154

Separation of Antithrombin Iii Alpha and Beta Variants by Cyclodextrin-Modified Micellar Electrokinetic Chromatography

Patent: 6,395,881 →